维普中文期刊产品整合服务
31篇 您的检索式:作者名="Mitchell Bruce"
    题名 作者 年代 出处 被引量
1卒中或短暂性脑缺血发作患者的卒中预防指南 美国心脏协会/美国卒中协会为医疗卫生专业人员制定的指南显示文摘本指南旨在为缺血性卒中或短暂性脑缺血发作存活患者的卒中预防提供全面和及时的循证推荐,包括危险因素的控制、动脉粥样硬化性疾病的于预、心源性栓塞的抗栓治疗以及非心源性栓塞性卒中的抗血小板治疗。另外,还对其他许多特殊情况下的复发性卒中预防提供了推荐意见,包括动脉夹层分离、卯圆孔未闭、高同型半胱氨酸血症、高凝状态、镰状细胞病、脑静脉窦血栓形成、女性卒中(尤其是与妊娠和绝经后雌激素替代治疗相关性卒中)、脑出血后抗凝药的使用等,以及实施本指南及其在高危人群中应用的特定方法。Karen L. Furie Scott E. Kasner Robert J. Adams Gregory W. Albers Ruth L. Bush Susan C. Fagan Jonathan L. Halperin S. Claiborne Johnston Irene Katzan Walter N. Kernan Pamela H. Mitchell Bruce Ovbiagele Yuko Y. Palesch Ralph L. Sacco Lee H. Schwamm Sylvia Wassertheil-Smoller Tanya N. Turan Deidre Wentworth 李海峰(译) 刘涛(译) 杨潘(译) 王鹏(译) 2011国际脑血管病杂志2011,19,1:391
2Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association显示文摘Karen L. Furie Scott E. Kasner Robert J. Adams Gregory W. Albers Ruth L. Bush Susan C. Fagan Jonathan L. Halperin S. Claiborne Johnston Irene Katzan Walter N. Kernan Pamela H. Mitchell Bruce Ovbiagele Yuko Y. Palesch Ralph L. Sacco Lee H. Schwamm Sylvia W 2011Stroke2011,,1:8
3Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association显示文摘Karen L. Furie Scott E. Kasner Robert J. Adams Gregory W. Albers Ruth L. Bush Susan C. Fagan Jonathan L. Halperin S. Claiborne Johnston Irene Katzan Walter N. Kernan Pamela H. Mitchell Bruce Ovbiagele Yuko Y. Palesch Ralph L. Sacco Lee H. Schwamm Sylvia W 2011Stroke2011,,1:2
4巴厘:可持续发展、旅游和沿海管理显示文摘印度尼西亚的巴厘(Bali)以其独特的景观和文化以及竞争性开发压力,提供了一个检验可持续发展概念的缩影。在推行鼓励经济蓬勃发展的政策,同时增进传统文化和保护自然环境完整性的过程中,巴厘正在遇到重大挑战。可持续发展的这些方面,成为'巴厘可持续发展项目'(BSDP)期间制定的、用于评价机会和压力的7项标准的根源。本文的注意点集中在一个方面:沿海环境中的旅游开发。旅游和其他开发的压力已导致沿海生态系统的破碎和退化,沿海侵蚀、沉积和再生过程的改变,以及沿海资源利用方面的不公平(尤其是当地人,与其传统活动相比更显得不公平)。我们在文化旅游政策方面提出一种综合方法,用来保护和恢复各种相互联系的沿海生态系统。Drew Knight Bruce Mitchell Geoffrey Wall 张康生 1997人类环境杂志1997,26,2:2
5Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor显示文摘Stephen J. Murphy Steven N. Hart Joema Felipe Lima Benjamin R. Kipp Mitchell Klebig Jennifer L. Winters Csilla Szabo Lizhi Zhang Bruce W. Eckloff Gloria M. Petersen Steven E. Scherer Richard A. Gibbs Robert R. McWilliams George Vasmatzis Fergus J. Couch 2013Gastroenterology2013,,5:1
6Differential Epidural Block Predicts the Success of Visceral Block in Patients with Chronic Visceral Abdominal Pain显示文摘Maged K. Rizk Reda Tolba Leonardo Kapural Justin Mitchell Rocio Lopez Ramatia Mahboobi Bruce Vrooman Nagy Mekhail 2012Pain Practice2012,,8:1
7Inventorying heavy metal pollution in redeveloped brownfield and its policy contribution: Case study from Tiexi District, Shenyang, China显示文摘Wanxia Ren Bing Xue Yong Geng Lina Sun Zhixiao Ma Yunsong Zhang Bruce Mitchell Liming Zhang 2014Land Use Policy2014,,:1
8Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase Ⅱ randomised placebo-controlled double-blind multicentre trial显示文摘Rationale Haematoma growth is common early after intracerebral haemorrhage(ICH),and is a key determinant of outcome.Tranexamic acid,a widely available antifibrinolytic agent with an excellent safety profile,may reduce haematoma growth.Methods and design Stopping intracerebral haemorrhage with tranexamic acid for hyperacute onset presentation including mobile stroke units(STOP-MSU)is a phase Ⅱ double-blind,randomised,placebo-controlled,multicentre,international investigator-led clinical trial,conducted within the estimand statistical framework.Hypothesis In patients with spontaneous ICH,treatment with tranexamic acid within 2 hours of onset will reduce haematoma expansion compared with placebo.Sample size estimates A sample size of 180 patients(90 in each arm)would be required to detect an absolute difference in the primary outcome of 20%(placebo 39%vs treatment 19%)under a two-tailed significance level of 0.05.An adaptive sample size re-estimation based on the outcomes of 144 patients will allow a possible increase to a prespecified maximum of 326 patients.Intervention Participants will receive 1 g intravenous tranexamic acid over 10 min,followed by 1 g intravenous tranexamic acid over 8 hours;or matching placebo.Primary efficacy measure The primary efficacy measure is the proportion of patients with haematoma growth by 24±6 hours,defined as either≥33%relative increase or≥6 mL absolute increase in haematoma volume between baseline and follow-up CT scan.Discussion We describe the rationale and protocol of STOP-MSU,a phase Ⅱ trial of tranexamic acid in patients with ICH within 2 hours from onset,based in participating mobile stroke units and emergency departments.Nawaf Yassi Henry Zhao Leonid Churilov Bruce C V Campbell Teddy Wu Henry Ma Andrew Cheung Timothy Kleinig Helen Brown Philip Choi Jiann-Shing Jeng Annemarei Ranta Hao-Kuang Wang Geoffrey C Cloud Rohan Grimley Darshan Shah Neil Spratt Der-Yang Cho Karim Mahawish Lauren Sanders John Worthington Ben Clissold Atte Meretoja Vignan Yogendrakumar Mai Duy Ton Duc Phuc Dang Nguyen Thai My Phuong Huy-Thang Nguyen Chung Y Hsu Gagan Sharma Peter J Mitchell Bernard Yan Mark W Parsons Christopher Levi Geoffrey A Donnan Stephen M Davis 2022Stroke & Vascular Neurology2022,7,2:1
9Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association显示文摘Karen L. Furie Scott E. Kasner Robert J. Adams Gregory W. Albers Ruth L. Bush Susan C. Fagan Jonathan L. Halperin S. Claiborne Johnston Irene Katzan Walter N. Kernan Pamela H. Mitchell Bruce Ovbiagele Yuko Y. Palesch Ralph L. Sacco Lee H. Schwamm Sylvia W 2011Stroke2011,,1:1
10Production of acrylic acid through nickel-mediated coupling of ethylene and carbon dioxide-A DFT study显示文摘Graham D C Mitchell C Bruce M I 2007Organomet2007,27,:1
11Structure and Thermodynamic Characterization of the EphB4/Ephrin-B2 Antagonist Peptide Complex Reveals the Determinants for Receptor Specificity显示文摘Jill E. Chrencik Alexei Brooun Michael I. Recht Michelle L. Kraus Mitchell Koolpe Anand R. Kolatkar Richard H. Bruce Georg Martiny-Baron Hans Widmer Elena B. Pasquale Peter Kuhn 2006Structure2006,,2:1
12The S pot sign and T ranexamic acid O n P reventing ICH growth – AUS tralasia T rial ( STOP‐AUST ): Protocol of a phase II randomized, placebo‐controlled, double‐blind, multicenter trial显示文摘Atte Meretoja Leonid Churilov Bruce C. V. Campbell Richard I. Aviv Nawaf Yassi Christen Barras Peter Mitchell Bernard Yan Harshal Nandurkar Christopher Bladin Tissa Wijeratne Neil J. Spratt Jim Jannes Jonathan Sturm Jayantha Rupasinghe Jorge Zavala Andrew 2014Int J Stroke2014,,:1
13The preservation of red cell antigens at low ionic strength显示文摘Allan JC Bruce M Mitchell R 1990Transfusion1990,30,5:1
14The effects of vertical and horizontal power on individual motivation and satisfaction显示文摘Drake Bruce and Mitchell Terence 1977Academy of Management Journal1977,20,4:1
15SPECIAL ARTICLE显示文摘Jian-ming Li Robert S. Podolsky Michael J. Rohrer Bruce S. Cutler Mitchell T. Massie Marc R. Barnard Alan D. Michelson 1996Journal of Surgical Research1996,,2:1
16Building materials can be a major source of indoo -r air pollution 显示文摘Mitchell Bruce 2013Occupational health & safety2013,82,9:1
17High heat sink jet fuels, part 1 : development of potential oxidative and pyrolytic additives for jp-8 显示文摘Bruce D Beaver Caroline Burgess Clifford Mitchel G Fedak 2006Energy and Fuels2006,20,4:1
18卒中和短暂性脑缺血发作患者的卒中预防指南(续前)美国心脏协会/美国卒中协会为医疗卫生专业人员制定的指南显示文摘5非心源性栓塞性卒中或TIA的抗栓治疗 5.1抗血小板药 FDA已批准4种抗血小板药用于预防卒中或TIA患者的血管事件:阿司匹林、阿司匹林/双嘧达莫联合应用、氯吡格雷和噻氯匹定。平均而言,这些药物能使卒中、MI或死亡的船降低22%,但这些药物之间存在重要的差异,这会直接影响治疗的选择。洪道俊 黄招君 李小兵 周美鸿 吴成斯 王博 卢艺 吴裕臣 Walter N. Kernan Bruce Ovbiagele Henry R. Black Dawn M. Bravata Marc I. Chimowitz Michael D. Ezekowitz Margaret C. Fang Marc Fisher Karen L. Furie Donald V. Heck S. Claiborne (Clay) Johnston Scott E. Kasner Steven J. Kittner Pamela H. Mitchell 2. .. Michael wl Rich DeJuran .Nchardson Lee H. Schwamm John A. Wilson 2014国际脑血管病杂志2014,22,12:1
19Solubility of niobium in the system CaCO 3 –CaF 2 –NaNbO 3 at 0.1 GPa pressure: implications for the crystallization of pyrochlore from carbonatite magma显示文摘Roger H. Mitchell Bruce A. Kjarsgaard 2004Contributions to Mineralogy and Petrology2004,,3:1
20Impaired cognitive function in patients with atherosclerotic carotid stenosis and correlation with ultrasound strain measurements显示文摘Brandon G. Rocque Daren Jackson Tomy Varghese Bruce Hermann Matthew McCormick Mark Kliewer Carol Mitchell Robert J. Dempsey 20122012 (1-2)2012,,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费